ABBVIE 19/31ABBVIE 19/31ABBVIE 19/31

ABBVIE 19/31

No trades
See on Supercharts

Key terms


Outstanding amount
‪650.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.25% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.02%
Maturity date
Nov 18, 2031
Term to maturity
6 years

About ABBVIE 19/31


Sector
Health Technology
Home page
Issue date
Sep 26, 2019
ISIN
XS2055647213
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.